Lantern Pharma Demonstrates ZETA AI Designing Cancer Drugs | The Future of AI-Driven Drug Discovery

For biotech investors, medical innovators, and AI researchers, this New to The Street reel highlights Lantern Pharma’s live demonstration of its ZETA AI platform, showing how artificial intelligence can think like a scientist to design new cancer drugs in real time by analyzing genomics, biomarkers, chemistry, dosing, and more across 438 rare cancers and over 560,000 indexed clinical trials, compressing years of drug discovery into minutes and offering a powerful roadmap for faster, smarter, and more affordable development of life-saving therapies.

#LanternPharma #AIDrugDiscovery #RareCancers #Biotech #ArtificialIntelligence #ZETA #ClinicalTrials #CancerResearch #MedicalInnovation #PrecisionMedicine #DrugDevelopment #FutureOfMedicine #HealthcareAI #BiotechInvesting #NewToTheStreet